Sacha Mann

She is a mentor in the health stream at the Creative Destruction Lab in Vancouver, and has participated on the board of non-profits. She was previously based in London where she founded the C100UK to support the growth of Canadian entrepreneurs as they scale their businesses into Europe.

Sacha is an experienced life science venture capital investor, board member, CEO and company builder. She has over 20 years of experience in venture investing, start-up leadership, biotech CEO, business development and industry research. Previously, Sacha was the Head of Genesis Labs and a Senior Partner at Takeda Ventures where she focused on early-stage biotech investments. She led investments in, and was on the board of, hC Bioscience, Larkspur Biosciences, and Egle Therapeutics. She also served as a member of the board of directors for Ribon, Ensoma, Crescendo and Oak Hill Bio.  She has been an advisor and director for various life science companies, incubators/accelerators, and venture capital funds. She was the CEO of Biosys, a venture-backed clinical stage GI company, and led several life science investments at Inventages. Prior to Inventages, Sacha was an early stage investor focused on innovation and investment at Archangels and BDC Capital. Sacha holds a BSc Honours in Chemistry from the University of British Columbia, an MSc in Biotechnology from Johns Hopkins University, an MBA from Simon Fraser University and is a Kauffman Fellow.

Sacha Mann served her fellowship at Archangel Informal Investment under the mentorship of John Waddell. She is a member of Class 12.